The National Comprehensive Cancer Network® (NCCN®) has released the NCCN Guidelines for Patients™: Multiple Myeloma, available free of charge on NCCN.com. NCCN Guidelines for Patients™ are a new tool to help patients and their caregivers take a more active role in treatment.
FORT WASHINGTON, PA — The National Comprehensive Cancer Network (NCCN) recently announced the latest addition to the library of NCCN Guidelines for Patients™, the NCCN Guidelines for Patients™: Multiple Myeloma. This new resource is a patient-friendly translation of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Multiple Myeloma, which physicians use when determining appropriate cancer treatment. NCCN also offers NCCN Guidelines for Patients™ for Breast and Non-Small Cell Lung Cancers.
More than 20,000 new cases of multiple myeloma are diagnosed in the United States each year, with most cases occurring in older patients. Treatment of multiple myeloma has improved dramatically over the past decade with the introduction of new drugs and combination drug therapies, although the challenge of preventing recurrence remains.
The NCCN Guidelines™ are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms or “decision trees” that address every appropriate treatment option from initial work up throughout the course of the disease. The NCCN Guidelines for Patients™ translate these professional guidelines in a clear, step-by-step manner that patients can use as the basis for making decisions and discussing options with their physicians.
The NCCN Guidelines for Patients™ are available free of charge at NCCN.com, which also features additional informative articles for patients and caregivers.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.